Department of Immunology and Oncology, Centro Nacional de Biotecnología/Consejo Superior de Investigaciones Cientificas (CNB/CSIC), 28049-Madrid, Spain.
Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11200-5. doi: 10.1073/pnas.1207290109. Epub 2012 Jun 25.
On the basis mainly of pharmacological experiments, the p38α MAP kinase isoform has been established as an important regulator of immune and inflammatory responses. However, the role of the related p38γ and p38δ kinases has remained unclear. Here, we show that deletion of p38γ and p38δ impaired the innate immune response to lipopolysaccharide (LPS), a Toll-like receptor 4 (TLR4) ligand, by blocking the extracellular signal-regulated kinase 1/2 (ERK1/2) activation in macrophages and dendritic cells. p38γ and p38δ were necessary to maintain steady-state levels of tumor progression locus 2 (TPL2), the MKK kinase that mediates ERK1/2 activation after TLR4 stimulation. TNFα, IL-1β, and IL-10 production were reduced in LPS-stimulated macrophages from p38γ/δ-null mice, whereas IL-12 and IFNβ production increased, in accordance with the known effects of TPL2/ERK1/2 signaling on the induction of these cytokines. Furthermore, p38γ/δ-deficient mice were less sensitive than controls to LPS-induced septic shock, showing lower TNFα and IL-1β levels after challenge. Together, our results establish p38γ and p38δ as key components in innate immune responses.
主要基于药理学实验,p38α MAP 激酶同工型已被确定为免疫和炎症反应的重要调节剂。然而,相关的 p38γ 和 p38δ 激酶的作用仍不清楚。在这里,我们表明 p38γ 和 p38δ 的缺失通过阻断巨噬细胞和树突状细胞中细胞外信号调节激酶 1/2(ERK1/2)的激活,损害了对脂多糖(LPS)的先天免疫反应,LPS 是 Toll 样受体 4(TLR4)配体。p38γ 和 p38δ 对于维持肿瘤进展位点 2(TPL2)的稳态水平是必需的,TPL2 是介导 TLR4 刺激后 ERK1/2 激活的 MKK 激酶。与 TPL2/ERK1/2 信号传导对这些细胞因子诱导的已知作用一致,LPS 刺激的 p38γ/δ 缺失型巨噬细胞中 TNFα、IL-1β 和 IL-10 的产生减少,而 IL-12 和 IFNβ 的产生增加。此外,与对照相比,p38γ/δ 缺失型小鼠对 LPS 诱导的败血症休克的敏感性较低,在受到挑战后 TNFα 和 IL-1β 水平较低。总之,我们的结果确立了 p38γ 和 p38δ 是先天免疫反应的关键组成部分。